Evidence map›Paper›PMID 33647019›Full record

ArticlePloS one2021

Reference intervals of common clinical biochemistry analytes in young Nigerian adults.

Ojor Ayemoba, Nathan Okeji, Nurudeen Hussain, Tahir Umar, Anthony Ajemba-Life, Terfa Kene, Uchechukwu Edom, Ikechukwu Ogueri, Goodluck Nwagbara, Inalegwu Ochai and 2 more

Abstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Ojor AyemobaMinistry of Defence Health Implementation Programme, Abuja, Nigeria.ORCID 0000-0003-2443-0323
Nathan OkejiMinistry of Defence Health Implementation Programme, Abuja, Nigeria.
Nurudeen HussainMinistry of Defence Health Implementation Programme, Abuja, Nigeria.
Tahir UmarMinistry of Defence Health Implementation Programme, Abuja, Nigeria.
Anthony Ajemba-LifeMinistry of Defence Health Implementation Programme, Abuja, Nigeria.
Terfa KeneAve Health Sense Ltd, Abuja, Nigeria.
Uchechukwu EdomMinistry of Defence Health Implementation Programme, Abuja, Nigeria.
Ikechukwu OgueriMinistry of Defence Health Implementation Programme, Abuja, Nigeria.
Goodluck NwagbaraMinistry of Defence Health Implementation Programme, Abuja, Nigeria.
Inalegwu OchaiMinistry of Defence Health Implementation Programme, Abuja, Nigeria.
Usman AdekanyeMinistry of Defence Health Implementation Programme, Abuja, Nigeria.
Ikenna OnohNigerian Field Epidemiology and Laboratory Training Programme, Abuja, Nigeria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundReference intervals are assessment tools for interpretation of clinical test results. These intervals describe the dispersion of test parameter values of apparently healthy persons in defined populations as health status indicators. Using reference intervals obtained and validated in populations outside the geographical region of derivation for medical decision-making may impact negatively on clinical interpretation and patient management. Many countries have established their reference values, current studies on these data for Nigeria are however scarce. Determination of clinical biochemistry reference intervals for young Nigerian adults which is of particular importance in routine clinical management and conduct of clinical trials in response to existing and emerging diseases will add significantly to the existing body of knowledge.

objectiveThe objective was to establish reference intervals for 24biochemistry analytes among Nigerians aged 18 to 26 years.

methodsThis was a cross-sectional study among 7,797 consenting male and female military applicants aged 18 to 26 years from 37 States of Nigeria. It was a total study among volunteers for military service. Blood samples were collected and subjected to serological testing for HIV-1 and 2, hepatitis-B, malaria, pregnancy and haematuria to restrict our study population to apparently healthy participants. Biochemical assays were performed on 6,169 participant samples that met the inclusion criteria. Generated data was entered into MS Excel® and exported into SPSS® software version 16 for analysis. Statistical tools used were frequencies, median, mid 95th percentile range with 2.5th and 97.5th percentiles as limits. Reference intervals were estimated using nonparametric methods. No intergender statistical comparison was made.

resultsComplete records were obtained for 6,169 eligible participants. Median values and associated reference intervals were similar in both genders.

conclusionThe findings from this study will help in clinical decision-making and play a significant role in supporting the current global rapid expansion of clinical trials in response to the urgent need for preventive and therapeutic solutions to existing and emerging diseases.

Indexed as

Healthy VolunteersMilitary PersonnelAdolescentAdultAlanine TransaminaseAlkaline PhosphataseAmylasesAspartate AminotransferasesBilirubinCholesterol, HDLCholesterol, LDLDiagnostic Tests, RoutineFemalegamma-GlutamyltransferaseHumansMaleAlanine TransaminaseAlkaline PhosphataseAmylasesAspartate AminotransferasesBilirubinCholesterol, HDLCholesterol, LDLgamma-GlutamyltransferaseSerum AlbuminTriglycerides

Identifiers

PMID33647019
PMCPMC7920356

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.